Prenetics Reports Record Q4 and FY 2025 Results: IM8 Achieves $120M ARR¹ in 12 Months, Revenue Surges 480% YoY

Core Insights - Prenetics Global Limited achieved record financial results in 2025, driven by the strong performance of its IM8 brand, marking a transformational year for the company [2][3][28] Financial Performance - Full-year revenue surged approximately 480% year-over-year to $92.4 million, with fourth quarter revenue reaching $36.6 million, a 55% increase quarter-over-quarter [3][41] - IM8 contributed $60.1 million in revenue for FY2025 and achieved an annualized recurring revenue (ARR) of approximately $120 million within just 12 months of launch [3][28] - Adjusted EBITDA loss improved by 27.2% year-over-year to $(13.0) million for FY2025, reflecting the capital efficiency of the IM8 business model [43][40] Strategic Actions - The company divested ACT Genomics for up to $72 million, sold the Europa distribution business for up to $13 million, and sold its stake in Insighta to Tencent for $70 million, enhancing its balance sheet to approximately $171 million in total adjusted liquidity [2][27][31] - The strategic transformation focused on streamlining operations and positioning IM8 as the core growth engine, resulting in a simplified operating structure [2][24][26] IM8 Brand Growth - IM8 was the primary growth driver, achieving a monthly revenue of $10 million in December 2025, with a 51% growth from Q3 to Q4 [4][3] - The brand's global reach expanded significantly, with over 60% of revenue generated outside the United States, indicating strong international demand [13][12] Customer Metrics - The total customer orders exceeded 230,000 in Q4 2025, with a 35% increase from Q3 [7] - The average order value increased to $133 in Q4 2025, reflecting a 31% growth from the previous quarter [7][18] Future Outlook - The company expects to triple IM8 revenue in 2026, targeting $180 million to $200 million, with a path towards $250 million to $300 million in ARR by the end of 2026 [30][32] - The transition to quarterly subscription plans is anticipated to enhance cash flow and customer lifetime value, with new blended average order values reaching approximately $233 in early 2026 [15][29]